The first Chinese medicine active ingredient preparation in the first synthetic biology produced by biology was permitted by the US FDA permission to conduct new drug clinical trials

School of Science and Technology of Chinese Medicine Sciences

Public account ID: CACMS1955

focus on

//

A few days ago, the new KH617 new preparations developed by Academician Huang Luqi of the Chinese Academy of Traditional Chinese Medicine and Academician Huang Luqi and the Tianjin Institute of Industrial Technology of the Chinese Academy of Sciences and the Sichuan Honghe Biotechnology Co., Ltd. have won the United States U.S. Food and Drug Administration (US Food and Drugs Authority, FDA) permission to conduct clinical trials of new drugs. China ’s clinical trial application has also been agreed to accept it by the National Drug Administration’ s Pharmaceutical Review Center. It is expected to become the first new plant natural product in the country to synthesize the source of biology. This preparation is developed into a new preparation for the production of high -purity raw materials produced by Chinese medicine activated ingredients in the synthetic biological method. It is intended to treat advanced physical tumors and recurrent gumocytoma. Preparation research combined with Sichuan University and drug effects confirmed by Harvard University Massachusetts General Hospital.

Synthetic biology is one of the contents of the fourteenth and fifth technologies. The new Chinese medicine anti -tumor preparations approved this time use synthetic biological technology to use biological synthetic pathways, efficient catalytic enzyme screening, and high -yield engineering bacteria. The acquisition has laid the foundation for the development of adults, and the research results have been authorized by domestic and foreign patents at home and abroad in China, the United States, and Japan. The raw materials produced by the strain do not rely on traditional planting methods and are not affected by environmental climate. As a source of alternative sources of active ingredients in traditional Chinese medicine, it effectively reduces the pressure on Chinese medicine resources. Studies from basic research to application transformation have realized the innovative development and utilization of "not acquired" traditional Chinese medicine resources.

Edit/typesetting: Zhang Lei

- END -